Evidence map›Paper›PMID 24052256›Full record

ArticleThe Journal of biological chemistry2013

Protein phosphatase 2A isoforms utilizing Aβ scaffolds regulate differentiation through control of Akt protein.

Justin H Hwang, Tao Jiang, Shreya Kulkarni, Nathalie Faure, Brian S Schaffhausen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Arctigenin inhibits prostate tumor cell growthClinical nutrition experimental · 2017
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Justin H HwangFrom the Department of Developmental, Molecular & Chemical Biology.
Tao Jiang
Shreya Kulkarni
Nathalie Faure
Brian S Schaffhausen
Arthur M. Sackler Gallery · USInstitut thématique Génétique, génomique et bioinformatique · FRTufts University · US

Funding

VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAYP01CA050661 · NCI · DANA-FARBER CANCER INSTITUTE · PI HAHN, WILLIAM C. · 1989 to 2013
$35.8M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
NCI NIH HHS P01 CA050661NCI NIH HHS P01 CA50661NCI NIH HHS R01 CA034722NCI NIH HHS R01 CA34722
6 · The paper itself

Abstract

Protein phosphatase 2A (PP2A) regulates almost all cell signaling pathways. It consists of a scaffolding A subunit to which a catalytic C subunit and one of many regulatory B subunits bind. Of the more than 80 PP2A isoforms, 10% use Aβ as a scaffold. This study demonstrates the isoform-specific function of the A scaffold subunits. Polyomaviruses have shown the importance of phosphotyrosine, PI3K, and p53 in transformation. Comparisons of polyoma and SV40 small T antigens implicate Aβ in the control of differentiation. Knockdown of Aβ enhanced differentiation. Akt signaling regulated differentiation; its activation or inhibition promoted or blocked it, respectively. Aβ bound Akt. Enhancement of PP2A Aβ/Akt interaction by polyoma small T antigen increased turnover of Akt Ser-473 phosphorylation. Conversely, knockdown of Aβ promoted Akt activity and reduced turnover of phosphate at Ser-473 of Akt. These data provide new insight into the regulation of Akt, a protein of extreme importance in cancer. Furthermore, our results suggest that the role for Aβ in differentiation and perhaps tumor suppression may lie partly in its ability to negatively regulate Akt.

Indexed as

Cell Differentiation3T3-L1 CellsAmyloid beta-PeptidesAnimalsAntigens, Polyomavirus TransformingGene Knockdown TechniquesHumansIsoenzymesMiceNeoplasmsPhosphatidylinositol 3-KinasesPhosphorylationPolyomavirusProtein Phosphatase 2Proto-Oncogene Proteins c-aktTumor Suppressor Protein p53Amyloid beta-PeptidesAntigens, Polyomavirus TransformingIsoenzymesPhosphatidylinositol 3-KinasesProtein Phosphatase 2Proto-Oncogene Proteins c-aktTumor Suppressor Protein p53AktDifferentiationPI 3-Kinase (PI3K)PolyomavirusPP2AProtein KinasesProtein PhosphataseSV40

Identifiers

PMID24052256
PMCPMC3814800
OpenAlexW2035810593

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.